GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.55M | 2.75M | 7.44M | 7.49M | 2.36M |
Total Receivables | 2.06M | 2.22M | 1.40M | 1.41M | 2.65M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 289.90K | 312.30K | 1.13M | 1.13M | 1.80M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 634.60K | 683.70K | 3.99M | 4.01M | 413.40K |
Total Current Assets | 5.53M | 5.96M | 13.95M | 14.04M | 7.22M |
|
|||||
Total Current Assets | 5.53M | 5.96M | 13.95M | 14.04M | 7.22M |
Net Property, Plant & Equipment | 965.90K | 1.04M | 1.48M | 1.49M | 2.24M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 59.00K | 63.60K | 70.70K | 71.20K | 82.90K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.58M | 4.93M | 556.10K | 559.90K | 556.00K |
Total Assets | 11.14M | 12.00M | 16.06M | 16.17M | 10.09M |
|
|||||
Total Accounts Payable | 6.58M | 7.09M | 5.13M | 5.16M | 6.23M |
Total Accrued Expenses | 1.79M | 1.93M | 1.72M | 1.73M | 1.98M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 14.39M | 15.50M | 7.14M | 7.19M | 19.21M |
Total Finance Division Other Current Liabilities | 651.20K | 701.50K | 4.08M | 4.11M | 539.40K |
Total Other Current Liabilities | 651.20K | 701.50K | 4.08M | 4.11M | 539.40K |
Total Current Liabilities | 23.42M | 25.23M | 18.07M | 18.19M | 27.95M |
|
|||||
Total Current Liabilities | 23.42M | 25.23M | 18.07M | 18.19M | 27.95M |
Long-Term Debt | 4.87M | 5.24M | 16.56M | 16.67M | 5.65M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 532.10K | 573.30K | 603.20K | 607.40K | 1.16M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 10.19M | 10.98M | 7.44M | 7.49M | 9.27M |
Total Liabilities | 39.01M | 42.02M | 42.67M | 42.96M | 44.03M |
|
|||||
Common Stock & APIC | 217.13M | 233.91M | 218.57M | 220.08M | 212.86M |
Retained Earnings | -14.50M | -15.62M | -6.27M | -6.31M | -28.98M |
Treasury Stock & Other | -230.50M | -248.32M | -238.92M | -240.57M | -217.81M |
Total Common Equity | -27.87M | -30.02M | -26.61M | -26.79M | -33.94M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -27.87M | -30.02M | -26.61M | -26.79M | -33.94M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -27.87M | -30.02M | -26.61M | -26.79M | -33.94M |
|